The story of Viagra and its influence on the pharmaceutical landscape presents a complex question for potential backers. Initially a massive drug, generics have significantly eroded its market presence , creating obstacles for companies participating to the original patent holder and subsequent formulas. While some firms might gain from niche Viagr